Futura Historical Income Statement

FUM Stock

32.95 0.22 0.66%

Historical analysis of Futura Medical income statement accounts such as Other Operating Expenses of 10.6 M or Research Development of 2.6 M can show how well Futura Medical performed in making a profits. Evaluating Futura Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Futura Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Futura Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Futura Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Futura Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Futura Income Statement Analysis

Futura Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Futura Medical shareholders. The income statement also shows Futura investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Futura Medical Income Statement Chart

At present, Futura Medical's Other Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Research Development is expected to grow to about 2.6 M, whereas EBIT is projected to grow to (6.6 M).

Interest Expense Other Operating Expenses Ebit Research Development Total Operating Expenses Selling General Administrative

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Futura Medical. It is also known as Futura Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Futura Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Futura Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Futura Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Futura Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Cost Of Revenue	Selling General Administrative	Total Revenue	Gross Profit	Net Income From Continuing Ops	Tax Provision	Net Interest Income	Interest Income	Reconciled Depreciation
Depreciation And Amortization		-0.51	0.69	-0.39	-0.39	-0.04	-0.38	0.59	-0.38	0.47	-0.49	0.13	0.9	0.96	0.97	0.94	-0.54	0.42	0.9	0.9	0.99
Interest Expense	-0.51		-0.22	0.07	0.07	0.17	0.07	-0.17	0.07	0.2	0.13	-0.17	-0.44	-0.49	-0.44	-0.43	0.16	-0.34	-0.21	-0.21	-0.49
Other Operating Expenses	0.69	-0.22		-0.93	-0.93	0.67	-0.93	0.99	-0.93	0.31	-0.97	-0.61	0.45	0.64	0.57	0.53	-0.96	-0.28	0.63	0.63	0.64
Operating Income	-0.39	0.07	-0.93		1.0	-0.88	1.0	-0.97	1.0	-0.12	0.99	0.85	-0.12	-0.34	-0.23	-0.19	0.96	0.55	-0.32	-0.32	-0.32
Ebit	-0.39	0.07	-0.93	1.0		-0.88	1.0	-0.97	1.0	-0.12	0.99	0.85	-0.12	-0.34	-0.23	-0.19	0.96	0.55	-0.32	-0.32	-0.32
Research Development	-0.04	0.17	0.67	-0.88	-0.88		-0.88	0.76	-0.88	-0.03	-0.81	-0.98	-0.25	-0.13	-0.18	-0.2	-0.78	-0.81	-0.03	-0.03	-0.11
Ebitda	-0.38	0.07	-0.93	1.0	1.0	-0.88		-0.97	1.0	-0.12	0.99	0.85	-0.11	-0.33	-0.22	-0.18	0.96	0.56	-0.31	-0.31	-0.31
Total Operating Expenses	0.59	-0.17	0.99	-0.97	-0.97	0.76	-0.97		-0.97	0.25	-0.99	-0.7	0.34	0.55	0.46	0.43	-0.98	-0.38	0.53	0.53	0.53
Income Before Tax	-0.38	0.07	-0.93	1.0	1.0	-0.88	1.0	-0.97		-0.12	0.99	0.85	-0.12	-0.34	-0.23	-0.19	0.96	0.55	-0.32	-0.32	-0.32
Total Other Income Expense Net	0.47	0.2	0.31	-0.12	-0.12	-0.03	-0.12	0.25	-0.12		-0.17	0.11	0.45	0.42	0.54	0.54	-0.17	0.23	0.64	0.64	0.49
Net Income	-0.49	0.13	-0.97	0.99	0.99	-0.81	0.99	-0.99	0.99	-0.17		0.77	-0.23	-0.45	-0.34	-0.3	0.98	0.46	-0.42	-0.42	-0.43
Income Tax Expense	0.13	-0.17	-0.61	0.85	0.85	-0.98	0.85	-0.7	0.85	0.11	0.77		0.35	0.19	0.28	0.31	0.73	0.84	0.14	0.14	0.2
Cost Of Revenue	0.9	-0.44	0.45	-0.12	-0.12	-0.25	-0.11	0.34	-0.12	0.45	-0.23	0.35		0.86	0.94	0.92	-0.35	0.48	0.89	0.89	0.93
Selling General Administrative	0.96	-0.49	0.64	-0.34	-0.34	-0.13	-0.33	0.55	-0.34	0.42	-0.45	0.19	0.86		0.94	0.92	-0.49	0.46	0.85	0.85	0.97
Total Revenue	0.97	-0.44	0.57	-0.23	-0.23	-0.18	-0.22	0.46	-0.23	0.54	-0.34	0.28	0.94	0.94		1.0	-0.4	0.5	0.94	0.94	0.98
Gross Profit	0.94	-0.43	0.53	-0.19	-0.19	-0.2	-0.18	0.43	-0.19	0.54	-0.3	0.31	0.92	0.92	1.0		-0.36	0.51	0.94	0.94	0.96
Net Income From Continuing Ops	-0.54	0.16	-0.96	0.96	0.96	-0.78	0.96	-0.98	0.96	-0.17	0.98	0.73	-0.35	-0.49	-0.4	-0.36		0.46	-0.48	-0.48	-0.48
Tax Provision	0.42	-0.34	-0.28	0.55	0.55	-0.81	0.56	-0.38	0.55	0.23	0.46	0.84	0.48	0.46	0.5	0.51	0.46		0.3	0.3	0.46
Net Interest Income	0.9	-0.21	0.63	-0.32	-0.32	-0.03	-0.31	0.53	-0.32	0.64	-0.42	0.14	0.89	0.85	0.94	0.94	-0.48	0.3		1.0	0.92
Interest Income	0.9	-0.21	0.63	-0.32	-0.32	-0.03	-0.31	0.53	-0.32	0.64	-0.42	0.14	0.89	0.85	0.94	0.94	-0.48	0.3	1.0		0.92
Reconciled Depreciation	0.99	-0.49	0.64	-0.32	-0.32	-0.11	-0.31	0.53	-0.32	0.49	-0.43	0.2	0.93	0.97	0.98	0.96	-0.48	0.46	0.92	0.92

Click cells to compare fundamentals

Futura Medical Account Relationship Matchups

Futura Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	20.7K	25.0K	19.8K	24.7K	130.3K	136.8K
Other Operating Expenses	11.2M	2.9M	5.9M	6.9M	10.1M	10.6M
Operating Income	(11.2M)	(2.9M)	(5.9M)	(6.9M)	(7.0M)	(6.6M)
Ebit	(11.2M)	(2.9M)	(5.9M)	(6.9M)	(7.0M)	(6.6M)
Research Development	10.1M	1.9M	3.8M	4.1M	2.0M	2.6M
Ebitda	(11.1M)	(2.9M)	(5.8M)	(6.8M)	(6.8M)	(6.5M)
Total Operating Expenses	11.2M	2.9M	5.9M	6.9M	8.7M	9.2M
Income Before Tax	(11.1M)	(2.9M)	(5.9M)	(6.9M)	(6.9M)	(6.5M)
Total Other Income Expense Net	22.3K	924.0	39.5K	(99.5K)	71.8K	75.4K
Net Income	(8.9M)	(2.4M)	(5.0M)	(5.8M)	(6.5M)	(6.2M)
Income Tax Expense	(2.2M)	(519.1K)	(908.6K)	(1.0M)	(379.1K)	(398.0K)
Selling General Administrative	1.1M	1.0M	2.1M	2.7M	6.7M	7.0M
Gross Profit	31.8K	(25.0K)	(19.8K)	(24.7K)	1.8M	1.9M
Net Income From Continuing Ops	(8.9M)	(2.4M)	(5.0M)	(5.8M)	(6.5M)	(6.8M)
Net Income Applicable To Common Shares	(5.9M)	(8.9M)	(2.4M)	(5.0M)	(4.5M)	(4.7M)
Tax Provision	(2.2M)	(519.1K)	(908.6K)	(1.0M)	(379.1K)	(398.0K)
Net Interest Income	27.6K	22.3K	924.0	0.0	71.8K	75.4K
Interest Income	27.6K	22.3K	924.0	0.0	71.8K	75.4K
Reconciled Depreciation	20.7K	25.0K	19.8K	24.7K	130.3K	136.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Other Information on Investing in Futura Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Futura Historical Income Statement

About Futura Income Statement Analysis

Futura Medical Income Statement Chart

Interest Expense

Other Operating Expenses

Total Operating Expenses

Futura Medical income statement Correlations

Futura Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Futura Medical income statement Accounts

Also Currently Popular

Other Information on Investing in Futura Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebitda

Net Income	- 0.99	Total Operating Expenses
Net Income From Continuing Ops	- 0.98	Total Operating Expenses
Income Tax Expense	- 0.98	Research Development
Income Before Tax	- 0.97	Total Operating Expenses
Total Operating Expenses	- 0.97	Ebitda
Total Operating Expenses	- 0.97	Ebit